Myocardial Infarction
📧 Sign up to get email alerts when something new happens for Myocardial Infarction.
Sign up freeTop drugs studied for this disease
-
FDA approval · 2018-03-07FDA Approved: EPTIFIBATIDE — Original Application (Sagent Pharmaceuticals)
FDA approved EPTIFIBATIDE from Sagent Pharmaceuticals via an Original Application, marking regulatory approval for this product.
-
CLINICAL_TRIALS trial_result · 2018-03-05Clinical Trial Update: The Effect of 12 Lead ECG Telemetry on Reperfusion Time in Resource-limited Settings [NA]
A completed clinical trial evaluated whether 12-lead ECG telemetry can reduce reperfusion time in patients with myocardial infarction and ST…
-
FDA approval · 2018-02-28FDA Approved: TNKASE — Supplemental Application (Genentech, Inc.)
The FDA approved a supplemental application for TNKASE (tenecteplase) from Genentech, Inc.
-
CLINICAL_TRIALS research · 2018-02-28Clinical Trial Update: Health Professionals Follow-up Study
Health Professionals Follow-up Study, sponsored by Harvard School of Public Health, has completed its trial/update focused on cardiovascular…
-
CLINICAL_TRIALS trial_result · 2018-02-20Clinical Trial Update: Effect of Beta-blocker on Cardioprotective Effect of Remote Ischemic Conditioning [Phase 4]
Phase 4 trial update investigating whether a beta-blocker influences the cardioprotective effect of remote ischemic conditioning in myocardi…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2018-01-25Clinical Trial Update: Strengthening Transplantation Effects of Bone Marrow Mononuclear Cells With Atorvastatin in Myocardial Infarction [Phase 2]
Phase 2 clinical trial evaluating bone marrow mononuclear cells with atorvastatin to enhance transplantation effects in myocardial infarctio…
-
CLINICAL_TRIALS trial_result · 2018-01-25Clinical Trial Update: Transplantation Efficacy of Autologous Bone Marrow Mesenchymal Stem Cells With Intensive Atorvastatin in AMI Patients [Phase 2]
Phase 2 trial investigating autologous bone marrow mesenchymal stem cells with intensive atorvastatin for myocardial infarction; status not …
-
EMA withdrawal · 2018-01-04EMA Withdrawn: Clopidogrel Acino (clopidogrel) — Acino AG
Clopidogrel Acino has been withdrawn from the European market.
-
CLINICAL_TRIALS trial_result · 2017-12-11Clinical Trial Update: Determination of the Role of Oxygen in Suspected Acute Myocardial Infarction by Biomarkers [Phase 3]
Phase 3 trial update evaluating the role of oxygen in suspected acute myocardial infarction using biomarkers; the study has completed.
-
CLINICAL_TRIALS trial_result · 2017-12-11Clinical Trial Update: Effects of Oxygen Treatment on Mechanisms Involved in Ischemia-reperfusion Injury: A Pilot Study in Healthy Volunteers [Phase 1]
Phase 1 pilot study in healthy volunteers assessing how oxygen treatment influences mechanisms involved in ischemia-reperfusion injury.
-
CLINICAL_TRIALS research · 2017-12-06Clinical Trial Update: Remote Ischemic Conditioning to Attenuate Myocardial Death and Improve Operative Outcome. [Phase 2]
Phase 2 clinical trial update evaluating remote ischemic conditioning to attenuate myocardial injury and improve operative outcomes during c…
-
CLINICAL_TRIALS trial_result · 2017-12-06Clinical Trial Update: System Delay and Clinical Outcome Among Chinese Patients With AMI Treated With Reperfusion Therapy (MOODY Study)
This is an update on the MOODY clinical trial assessing system delays and clinical outcomes in Chinese patients with acute myocardial infarc…
-
CLINICAL_TRIALS trial_result · 2017-12-04Clinical Trial Update: Harmonizing Outcomes With Revascularization and Stents in Acute Myocardial Infarction [Phase 3]
Phase 3 clinical trial update on harmonizing outcomes with revascularization and stents in acute myocardial infarction; results have been po…
-
FDA approval · 2017-11-30FDA Approved: HEPARIN SODIUM — Original Application (Mylan Institutional LLC)
FDA approved an Original Application for HEPARIN SODIUM (generic) from Mylan Institutional LLC, authorizing marketing of this anticoagulant.…
-
CLINICAL_TRIALS trial_result · 2017-11-29Clinical Trial Update: Safety and Effectiveness of Intra-coronary Nitrite in Acute Myocardial Infarction [Phase 2]
Phase 2 clinical trial evaluating intracoronary nitrite in acute myocardial infarction has completed, assessing safety and effectiveness. Th…
-
CLINICAL_TRIALS trial_result · 2017-11-24Clinical Trial Update: Dietary Antioxidants and Chronic Diseases-The Swedish National March Cohort
A completed Swedish cohort study from Karolinska Institutet examined dietary antioxidants and their relationship to chronic diseases, includ…
-
CLINICAL_TRIALS trial_result · 2017-11-24Clinical Trial Update: Optical Coherence Tomography in Patients With Acute Myocardial Infarction and Nonobstructive Coronary Artery Disease [NA]
This clinical trial update notes the completion of a study evaluating optical coherence tomography in patients with acute myocardial infarct…
-
FDA approval · 2017-11-22FDA Approved: BIVALIRUDIN — Original Application (Accord Healthcare, Inc.)
FDA approved Accord Healthcare's generic version of bivalirudin, expanding access to the anticoagulant used to prevent clotting during proce…
-
CLINICAL_TRIALS research · 2017-11-21Clinical Trial Update: Optimal Strategy of Primary PCI for Left Main Coronary Artery Occlusion Induced AMI [NA]
This clinical trial assesses the optimal primary PCI strategy for acute myocardial infarction caused by left main coronary artery occlusion;…
-
CLINICAL_TRIALS trial_result · 2017-11-17Clinical Trial Update: MI Mortality Risk and Between-hospital Risk Variation in the United Kingdom and Sweden
A completed clinical trial examining mortality risk after acute myocardial infarction and how in-hospital risk varies across hospitals in th…
-
CLINICAL_TRIALS trial_result · 2017-11-17Clinical Trial Update: Short-Term Application of Tocilizumab Following Myocardial Infarction [NA]
Clinical trial update indicates short-term use of tocilizumab after myocardial infarction completed, with results posted.
-
CLINICAL_TRIALS research · 2017-11-17Clinical Trial Update: Partners and Alerts: A Study of Social Forces in Medication Adherence [NA]
A University of Pennsylvania study (NCT01890018) on the role of social forces in medication adherence among patients with acute myocardial i…
-
CLINICAL_TRIALS trial_result · 2017-11-14Clinical Trial Update: Safety and Efficacy Evaluation of Intracoronary Infusion of Allogeneic Human Cardiac Stem Cells in Patients With AMI [Phase 1, Phase 2]
Phase 1/2 trial evaluating intracoronary infusion of allogeneic human cardiac stem cells in patients with acute myocardial infarction has co…
-
CLINICAL_TRIALS research · 2017-11-14Clinical Trial Update: The ALERT-Pilot Study
The ALERT-Pilot Study is a pilot clinical trial focused on acute myocardial infarction using artificial intelligence for ECG pattern analysi…
-
CLINICAL_TRIALS trial_result · 2017-11-09Clinical Trial Update: Culprit Lesion Only PCI Versus Multivessel PCI in Cardiogenic Shock [Phase 4]
A Phase 4 clinical trial comparing culprit-lesion-only PCI with multivessel PCI in patients with cardiogenic shock and acute myocardial infa…